- Report
- February 2022
- 40 Pages
Brazil
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
China
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
France
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
Germany
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
Ireland
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
Japan
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
Russia
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
United States
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2022
- 40 Pages
Vietnam
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 80 Pages
Africa
From €1975EUR$2,000USD£1,649GBP
- Report
- January 2022
- 40 Pages
Brazil
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
China
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
France
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
Germany
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
Japan
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
Russia
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2022
- 40 Pages
United States
From €1481EUR$1,500USD£1,237GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more